Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194857 · ClinicalTrials.gov registry record · Phase 4
Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 4
- Development phase
NCT00194857 is a Phase 4 study that was terminated before completion, run by Weill Medical College of Cornell University.
The verdict
NCT00194857, a Phase 4 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
Study Summary
This study is designed to test two separate strategies for treatment of anemia (low hemoglobin) and neutropenia (low white blood cells) in HIV/HCV coinfected patients who are being treated with pegylated interferon and ribavirin.
Interventions
- DRUG erythropoietin, GCSF
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-02 |
| Est. Completion | 2005-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00194857
The ClinicalTrials.gov registry entry for NCT00194857 describes a study currently listed as terminated, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which erythropoietin, GCSF is the first listed.
NCT00194857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00194857 about?
NCT00194857 is a clinical study titled "Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin". This study is designed to test two separate strategies for treatment of anemia (low hemoglobin) and neutropenia (low white blood cells) in HIV/HCV coinfected patients who are being treated with pegylated interferon and ribavirin.
What is the current status of trial NCT00194857?
This trial is currently terminated. It is a Phase 4 study. The study started on 2002-02. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00194857?
The interventions under investigation include: erythropoietin, GCSF (DRUG).
Who is sponsoring clinical trial NCT00194857?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.